EDMONTON, AB – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company’s IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to medical cannabis options.
“This change to open up patient access to MedReleaf’s IndiMed products reflects our dedication to supporting prescribers by creating more seamless and simplified prescribing options,” said Andre Jerome, Executive Vice President, Global Business Development at Aurora. “It is a testament to our expertise in navigating international markets that we have the ability to quickly adapt and apply necessary change with ease, in order to meet patient demand in the rapidly growing medical cannabis market in Australia.”
IndiMed was launched in Australia in 2021 as the very first concession product in the market. Over the years, the IndiMed portfolio has expanded to include oil, additional dried flower product and resin cartridges. Today, IndiMed flower product is consistently ranked in the top 10 most prescribed flowers for cannabis patients.
MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality, consistency and proudly meets all TGA-GMP standards.
In addition, the company announced it has filed a final short-form base shelf prospectus with securities regulators in each of the provinces of Canada, except Quebec, and a corresponding shelf registration statement on Form F–10 with the United States Securities and Exchange Commission.
About Aurora Cannabis Inc.
Aurora serves both the medical and consumer markets across Canada, Europe, Australia, and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company’s adult-use brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., a leading North American supplier of propagated agricultural plants.
Aurora’s common shares trade on the NASDAQ and TSX under the symbol ACB.
